FACULTY
CHAIRPERSON
Professor Tony Mok
Department of Clinical Oncology
The Chinese University of Hong Kong
Shatin, Hong Kong
SPEAKER
Professor Haiquan Chen
Department of Thoracic Surgery
Fudan University Shanghai Cancer Center
Shanghai, China
SPEAKER
Professor Enriqueta Felip
Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain
SPEAKER
Professor Solange Peters
Department of Oncology
University Hospital of Lausanne
Lausanne, Switzerland
SPEAKER
Professor Yi-Long Wu
Guangdong Provincial People’s Hospital
and Guangdong Lung Cancer Institute
Southern Medical University
Guangzhou, China
AGENDA
| Time | Topic |
|---|---|
| 14:30–14:35 | Opening and introduction Professor Tony Mok |
| 14:35–15:05 | Management of early-stage NSCLC with driver mutations Professor Yi-Long Wu |
| 15:05–16:05 | Debate: All resectable stage II to III NSCLC patients should be treated with
neoadjuvant immunotherapies Pro Professor Enriqueta Felip Con: Professor Haiquan Chen |
| 16:05–16:20 | Tea break |
| 16:20–16:50 | Empowerment through precision: Treatment strategies for enhancing lives in
ALK+ NSCLC patients Professor Solange Peters |
| 16:50–17:20 | What’s new with ICI, ADC and antibodies for lung cancer? Professor Tony Mok |
| 17:20–17:50 | Panel discussion All speakers, moderated by Professor Tony Mok |
| 17:50–17:55 | Closing remarks Professor Tony Mok |
Hong Kong CME Accreditation
The Hong Kong College of Pathologists = 3 CME points
Hong Kong College of Physicians = 3 CME points
Hong Kong College of Radiologists = 3 CME points
The College of Surgeons of Hong Kong = 3 CME points